AGIO vs GLD
Agios Pharm (AGIO) versus SPDR® Gold Shares (GLD) — a side-by-side from cached financials, not a winner call.
Agios Pharm (AGIO) is a biotechnology company listed on US.
SPDR® Gold Shares (GLD) common stock listed on NYSE ARCA.
Latest reported AGIO revenue for 2026-06-30 was $65.5M. Net income was -$199.8M. AGIO currently screens at market cap $1.68B.
GLD does not have a complete income-statement cache yet.
AGIO currently screens at market cap $1.68B. GLD currently screens at market cap $0.
Not investment advice. Open the AGIO and GLD stock pages for the full models.
Not investment advice.